It was recently reported that the Epac inhibitor ESI-09 suppresses the proliferation of pancreatic tumor cells [15]; meanwhile, Epac1 is highly expressed in gastric cancer cells [16]. The gene discussed is RAPGEF3; the disease is gastric cancer.